openPR Logo
Press release

Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Breakthrough Insomnia Treatment Solutions

06-05-2023 07:03 AM CET | Health & Medicine

Press release from: Persistence Market Research

Insomnia Treatment Market

Insomnia Treatment Market

Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market.

Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to implement wearable devices and several other integrated applications for catering to healthcare needs. This would continue shortly as well.

Technological innovations have revolutionized lifestyle, communication, business, travel, and healthcare. The healthcare technology industry is continually improving ways to treat neural-related medical conditions, coupled with a significant understanding of subsequent ramifications and consequences. On the other hand, the pharmaceutical landscape has also transitioned and opened itself to explore novel scientific approaches and innovative technologies within its core therapeutic areas.

Get Free Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/23203

Company Profiles:

Sunovion Pharmaceuticals, Inc.
Natrol, LLC
GlaxoSmithKline Plc.
Sanofi SA
Pfizer Inc.
Boehringer Ingelheim International GmbH
Mallinckrodt
PERNIX Therapeutics
Takeda Pharmaceutical Company Limited
Merck & Co. Inc.
Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/23203

New Pharmaceutical Innovations to Address Key Concerns for Sleep Medications

In the 32nd Annual Meeting of the Associated Professional Sleep Societies (SLEEP 2018), Eisai Co., Ltd. and Purdue Pharma L.P showed positive results from clinical trials of lemborexant, which is currently being studied for the potential treatment of multiple sleep disorders, especially insomnia. On examining lemborexant for sleep onset, sleep maintenance, and return to sleep latency, it showed favorable results in terms of postural instability and residual effect compared to placebo and zolpidem (Ambien).

A number of pharmaceutical companies are setting new breakthroughs in the sleep medications segment to cater to specific and unmet needs of insomnia patients. Such innovations are expected to help improve sleep through the night and also allow patients to function appropriately upon awakening, which has been a growing concern among older adults.

Smart Goggles, Wearable Tracking Devices, & Others Are Here to Stay

Multiple companies in the market are working on wearable devices for insomnia treatment, one of which is smart goggles; patients can now be wearing a pair of smart goggles to sleep off. Recent studies indicate that smart goggles use light and sound stimulations to trigger specific patterns in the brain that would eventually induce sleep. The light emitted by the goggles is of a certain wavelength that stimulates the hypothalamus gland within the brain. This leads to controlled secretion of melatonin, a hormone responsible for sleeping patterns.

Additionally, FDA-approved at-home and wearable tracking devices that monitor brain activity, leg movement, and breathing are becoming more common in the sleep research field. Another 'chemical-free' alternative is telehealth, which involves various ways to communicate with patients about their sleep health. Doctors and researchers are likely to focus on telehealth in near future.

In another research, scientists have discovered that certain cells in the brains of mice, expresses a gene called Lhx6, which promotes sleep. On activation, the Lhx6 gene induces sleep in mice; and awakened mice when deactivated. Moreover, a similar gene is also found in the human hypothalamus gland, and is anticipated to be potentially studied for sleep regulation. It is most likely that the compounds with similar properties as the Lhx6 gene will be incorporated with insomnia drugs, for enhance effectiveness.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/23203

New Drug Formulations to Remain a Key Strategy among Pharmaceutical Industries

A recent study by Persistence Market Research indicates that OTC drugs contribute a maximum revenue share in the global insomnia treatment market, due to increasing preference among insomnia patients. To make insomnia treatment drugs more effective and occupy a greater share of revenue in the global market, the development of new drug formulations is foreseen to remain a key strategy among leading pharmaceutical industries.

Besides expanding geriatric population, some of the most common concerns such as dependency, addiction, and residual symptoms will further compel the requirement of transformed insomnia treatment market over the projection period, 2018-2026. The global market for insomnia treatment is expected to be valued at around US$ 7.5 Bn by 2026 end, witnessing steady expansion at 5.2% CAGR over 2018-2027.

While North America holds the substantial revenue share in the global insomnia treatment market, retail pharmacies are the most preferred to buy insomnia treatment drugs.

Persistence market research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About us: -

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductors and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Breakthrough Insomnia Treatment Solutions here

News-ID: 3077012 • Views:

More Releases from Persistence Market Research

Print Label Market to Reach US$ 68.6 Bn by 2031 Fueled by Rising Demand for Sustainable Packaging Solutions
Print Label Market to Reach US$ 68.6 Bn by 2031 Fueled by Rising Demand for Sust …
Market Overview According to the latest study by Persistence Market Research, the global print label market is expected to witness steady growth, expanding at a CAGR of 4.3% from US$ 51.1 Bn in 2024 to US$ 68.6 Bn by 2031. This growth is primarily driven by the rising demand for eco-friendly and customizable labeling solutions, technological advancements in printing, and increased application of printed labels in industries such as food &
Pipe Coating Market Valued at US$9.1 Billion in 2024, Projected to Reach US$12.6 Billion by 2031
Pipe Coating Market Valued at US$9.1 Billion in 2024, Projected to Reach US$12.6 …
The global pipe coating market is experiencing robust growth due to rapid infrastructure development, increasing energy demand, and the rising adoption of advanced protective coating technologies. Pipe coatings play a crucial role in extending the service life of pipelines by preventing corrosion, chemical damage, and mechanical wear. They are essential across industries such as oil and gas, water and wastewater management, construction, and chemical processing. As global industrialization continues to
North America High Voltage Direct Current (HVDC) Market to Reach US$5.8 Bn by 2031 Driven by Grid Modernization and Renewable Integration
North America High Voltage Direct Current (HVDC) Market to Reach US$5.8 Bn by 20 …
Market Overview According to the latest study by Persistence Market Research, the North America high voltage direct current (HVDC) market is poised for substantial growth, reaching a valuation of US$3.6 Bn in 2024 and projected to expand at a CAGR of 6.8% to attain US$5.8 Bn by 2031. The market's upward trajectory is primarily fueled by the growing demand for reliable, efficient, and long-distance electricity transmission infrastructure across the United States
High Temperature Coatings Market Size Worth US$4.13 Billion by 2032
High Temperature Coatings Market Size Worth US$4.13 Billion by 2032
The global market for high temperature coatings has experienced strong growth over the past decade, driven by rapid industrialization, increasing infrastructure development, and the growing need for materials that can withstand extreme heat conditions. These coatings are specifically engineered to protect surfaces exposed to elevated temperatures, oxidation, and corrosion. They play an essential role in maintaining structural integrity and performance efficiency in a wide range of industrial applications. As global

All 5 Releases


More Releases for Insomnia

Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Insomnia Market Size Growth Forecast: What to Expect by 2025? In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication. There are two types of insomnia primary and secondary. Primary insomnia
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom. The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases
Insomnia - US Drug Market: Rising Cases Of Insomnia To Be Biggest Driver
Insomnia is one of the common disorders affected to 35% of the worldwide population. Insomnia is primarily classified into primary and secondary subtypes. The number of people suffering from a sleep disorder, insomnia, is increasing in the United States. In the recent past, the launch of new products and drugs to treat insomnia has been benefiting the U.S. insomnia drugs market. The U.S. insomnia market is classified widely, which enables